This is promising, but the evidence is observational
Retatrutide is a next-generation triple-agonist weight loss peptide that simultaneously activates GLP-1, GIP, and glucagon receptors
However, the studies on the metabolic benefits of microdosing tirzepatide are still limited
Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis
doi: 10.1080/003655201750065906
Its products are made in NSF-GMPregistered facilities and undergo both in-house and independent lab testing for identity, potency, and contaminants (including heavy metals, solvents, and pesticides)